Toronto Dominion Bank
AZN icon

Toronto Dominion Bank’s AstraZeneca AZN Stock Holding History

Toronto Dominion Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,353
Closed -$1.9M – 2125
2025
Q4 		$1.9M Sell
10,353
-10,159
-50% -$1.78M ﹤0.01% 1133
2025
Q3 		$3.12M Sell
20,512
-6,773
-25% -$1.03M ﹤0.01% 917
2025
Q2 		$3.81M Buy
27,285
+8,276
+44% +$1.16M 0.01% 803
2025
Q1 		$2.79M Buy
19,009
+5,469
+40% +$791K 0.01% 847
2024
Q4 		$1.77M Buy
13,540
+4,575
+51% +$641K ﹤0.01% 949
2024
Q3 		$1.4M Buy
8,965
+1,204
+16% +$194K ﹤0.01% 814
2024
Q2 		$1.21M Sell
7,761
-1,486
-16% -$224K ﹤0.01% 868
2024
Q1 		$1.25M Buy
9,247
+1,224
+15% +$162K ﹤0.01% 853
2023
Q4 		$1.08M Buy
8,023
+3,842
+92% +$499K ﹤0.01% 970
2023
Q3 		$566K Buy
4,181
+2,097
+101% +$286K ﹤0.01% 1032
2023
Q2 		$299K Buy
2,084
+472
+29% +$69.4K ﹤0.01% 1096
2023
Q1 		$224K Buy
1,612
+268
+20% +$36.1K ﹤0.01% 1129
2022
Q4 		$182K Sell
1,344
-25
-2% -$3.13K ﹤0.01% 1236
2022
Q3 		$150K Buy
1,369
+212
+18% +$26.9K ﹤0.01% 1308
2022
Q2 		$153K Buy
1,157
+303
+35% +$39.8K ﹤0.01% 1091
2022
Q1 		$113K Buy
854
+254
+42% +$30.5K ﹤0.01% 1175
2021
Q4 		$70K Hold
600
– – ﹤0.01% 1344
2021
Q3 		$72K Hold
600
– – ﹤0.01% 1185
2021
Q2 		$72K Hold
600
– – ﹤0.01% 1175
2021
Q1 		$60K Hold
600
– – ﹤0.01% 1198
2020
Q4 		$60K Sell
600
-7,143
-92% -$757K ﹤0.01% 1138
2020
Q3 		$849K Buy
7,743
+6,913
+833% +$769K ﹤0.01% 866
2020
Q2 		$88K Buy
830
+230
+38% +$23.8K ﹤0.01% 1034
2020
Q1 		$54K Hold
600
– – ﹤0.01% 1042
2019
Q4 		$60K Hold
600
– – ﹤0.01% 1123
2019
Q3 		$53K Buy
+600
New +$52K ﹤0.01% 1215
2019
Q2 		– Sell
-913
Closed -$74K – 1460
2019
Q1 		$74K Sell
913
-1,551
-63% -$122K ﹤0.01% 1264
2018
Q4 		$188K Sell
2,464
-5,511
-69% -$430K ﹤0.01% 1106
2018
Q3 		$632K Buy
7,975
+61
+0.8% +$4.61K ﹤0.01% 961
2018
Q2 		$556K Buy
7,914
+1,475
+23% +$106K ﹤0.01% 1020
2018
Q1 		$450K Sell
6,439
-258
-4% -$17.9K ﹤0.01% 957
2017
Q4 		$465K Sell
6,697
-76
-1% -$5.13K ﹤0.01% 905
2017
Q3 		$460K Hold
6,773
– – ﹤0.01% 769
2017
Q2 		$462K Hold
6,773
– – ﹤0.01% 777
2017
Q1 		$423K Sell
6,773
-783
-10% -$45.6K ﹤0.01% 787
2016
Q4 		$413K Hold
7,556
– – ﹤0.01% 769
2016
Q3 		$498K Hold
7,556
– – ﹤0.01% 600
2016
Q2 		$459K Hold
7,556
– – ﹤0.01% 448
2016
Q1 		$424K Sell
7,556
-666
-8% -$40K ﹤0.01% 413
2015
Q4 		$560K Sell
8,222
-428
-5% -$28.1K ﹤0.01% 491
2015
Q3 		$553K Hold
8,650
– – ﹤0.01% 476
2015
Q2 		$551K Hold
8,650
– – ﹤0.01% 513
2015
Q1 		$592K Sell
8,650
-471
-5% -$32.7K ﹤0.01% 491
2014
Q4 		$641K Sell
9,121
-325
-3% -$23.3K ﹤0.01% 518
2014
Q3 		$1M Sell
9,446
-1,310
-12% -$95.9K ﹤0.01% 346
2014
Q2 		$798K Buy
10,756
+535
+5% +$38.7K ﹤0.01% 405
2014
Q1 		$688K Sell
10,221
-769
-7% -$49.7K ﹤0.01% 418
2013
Q4 		$652K Buy
10,990
+2,085
+23% +$113K ﹤0.01% 407
2013
Q3 		$461K Sell
8,905
-13,750
-61% -$691K ﹤0.01% 403
2013
Q2 		$1.07M Buy
+22,655
New +$1.15M ﹤0.01% 291

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Toronto Dominion Bank's AZN Position: Q1 2026 in Review

Toronto Dominion Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 10,353 shares — an estimated $1.9M sold.

Toronto Dominion Bank first reported a position in AZN in Q2 2013 and held it in 50 quarters. The position peaked at $3.81M in Q2 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Toronto Dominion Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 10,353 AstraZeneca shares in Q1 2026, an estimated $1.9M.
  • Toronto Dominion Bank first reported a position in AstraZeneca in Q2 2013 and held it in 50 quarters.
  • Toronto Dominion Bank's AstraZeneca position peaked at $3.81M in Q2 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.